WVVI exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a failure in nearly all fundamental health categories. While the company maintains a strong gross margin (60.47%) and trades at a significant discount to book value (P/B 0.59), these are offset by negative net profit margins and declining year-over-year revenue. The technical trend is completely bearish (0/100) with a devastating 5-year price collapse of 72.3%, suggesting the stock is a classic value trap.